Fludarabine/rituximab: Severe prolonged immunosuppression leading to fatal infection: 2 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1215, 2008-01, pp. : 19-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fludarabine/rituximab: Progressive multifocal leukoencephalopathy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Fludarabine/rituximab: Reactivation of hepatitis B: case report

By  

Reactions Weekly, Vol. 1, Iss. 1168, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine/rituximab: Reactivation of hepatitis B virus leading to fatal acute liver failure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Rituximab: Prolonged B cell depletion: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1221, 2008-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine/rituximab: Fatal progressive multifocal leukoencephalopathy and toxoplasmosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1319, 2010-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite